Description
OPEN MARKET - TAMSULOSIN
First action · last action
2015-06-11 · 2015-06-30
Transactions
3
First transaction's obligation
$1,502,109
Base + all options value (sum of deltas)
$1,360,577
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
13
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-06-11+$1,502,109= $1,502,109
- Mod P000012015-06-11+$0= $1,502,109
- Mod P000022015-06-30-$141,533= $1,360,577
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-06-11 | +$1,502,109 | $1,502,109 | OPEN MARKET - TAMSULOSIN |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2015-06-11 | +$0 | $1,502,109 | OPEN MARKET - TAMSULOSIN |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2015-06-30 | −$141,533 | $1,360,577 | OPEN MARKET - TAMSULOSIN |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PUM1KHA7QA79)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77025P0226 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $289,027 | FY2025 |
| 36F79725D0072 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $0 | FY2025 |
| 36F79724D0032 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36F79724D0004 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2024 |
| 36C77022P0383 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $21,067 | FY2022 |
| 36C77022P0319 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $66,420 | FY2022 |
Other recipients under 6505 from NATIONAL CMOP OFFICE (NCO) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA77016P0844 | ROCHE DIABETES CARE INC | NATIONAL CMOP OFFICE (NCO) | $494,384 | FY2016 |
| VA77016P0843 | D & H WHOLESALE MEDICAL, INC. | NATIONAL CMOP OFFICE (NCO) | $30,360 | FY2016 |
| VA77016E0865 | SOUND PACKAGING LLC | NATIONAL CMOP OFFICE (NCO) | $11,462 | FY2016 |
| VA77016P0828 | WESTMINSTER PHARMACEUTICALS, LLC | NATIONAL CMOP OFFICE (NCO) | $24,615 | FY2016 |
| VA77016E0862 | 3M COMPANY | NATIONAL CMOP OFFICE (NCO) | $9,177 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA77015P0579_3600_-NONE-_-NONE- · retrieved 2026-09-26.